Investigator Site 47 - US0010021 — Palo Alto, California

Investigator Site 47 - US0010021 is a clinical research site located in Palo Alto, California, United States 94304.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Investigator Site 47 - US0010021 has participated in 1 clinical trials.

Therapeutic areas: Generalized Myasthenia Gravis.

Sponsors: argenx.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator Site 47 - US0010021?

Investigator Site 47 - US0010021 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator Site 47 - US0010021 conducted?

Investigator Site 47 - US0010021 has 1 clinical trials on record. Their work covers Generalized Myasthenia Gravis.

Is Investigator Site 47 - US0010021 accredited by Crixeo Health?

Investigator Site 47 - US0010021 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator Site 47 - US0010021?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.